Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Neuromodulation Devices: World Industry and Market 2015-2025


News provided by

Visiongain

06 Jan, 2015, 14:00 GMT

Share this article

Share toX

Share this article

Share toX

LONDON, January 6, 2015 /PRNewswire/ --

Report Details 

Neuromodulation devices - your guide to trends, progress and revenue prospects 

See the future of medical devices to stimulate and treat the central nervous system (CNS). Those treatments hold high potential. Now you can explore sales forecasts and explore that industry's research and development (R&D).

Visiongain's new report predicts those revenues to 2025 at overall world market, submarket and national level. There you stay ahead in data and analysis on therapies, discovering medical, technological and commercial potentials and opportunities.

Read on to explore those neuronal treatments, seeing how high that industry's sales can go.

Forecasts and other analyses to help your research, knowledge and influence 

Avoid struggles to find business information on neuromodulation and neurostimulation. Instead discover what's happening in treating brain and other nervous system disorders. And now you can make your research, market appraisal and analysis easier and quicker.

Besides forecasting to 2025, our new study gives you recent results, growth rates, market shares and discussions. You get 75 charts, 28 tables and interviews with two companies.

Discover how competition and technological advances shape that industry. Also benefit your reputation for technological and commercial knowledge. See what's possible from now.

To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com

Forecasting of that world market and its segments 

Our study predicts overall world revenue to 2025 for neuromodulating and neurostimulating technologies and their uses.

There you also find individual revenue predictions to 2025 for five submarkets at world level:
• Spinal cord stimulation (SCS)
• Deep brain stimulation (DBS)
• Vagal nerve stimulation (VNS)
• Sacral nerve stimulation (SNS)
• Other techniques for modifying CNS activity.

You investigate the most promising and lucrative parts of the neuromodulators industry. See how it can progress. Our study predicts high, rising sales there. You explore how, where, when and why rapid market expansion can occur.

That work also splits its overall world market into geographical revenue predictions.

Healthcare in national markets - what outlooks for that business? 

Our analyses also show you individual revenue forecasts to 2025 for 12 countries:
• United States (US)
• Japan
• Germany, France, UK, Italy, Spain and Ireland, also with EU regional prediction
• Brazil, Russia, India and China (BRIC nations).

There you find countries with highest revenues, demand and potential sales. Explore progress, needs and opportunities, seeing how you can gain.

And how do changes, challenges and technological advances affect that industry and market?

Forces, events and issues - developments influencing that medical field 

The new report explains policies, trends and R&D shaping that industry and market, including these:
• Widening applications in treating pain, depression, epilepsy, incontinence, hearing disorders, heart conditions and neurodegenerative diseases, inc. Parkinson's
• Market trends - ageing populations raising demand, personalised healthcare, regulations and changes in that medical devices sector
• Emerging technology - cochlear implants, transmagnetic stimulation (TMS), transcranial direct current stimulation (tDCS) and ultrasonic applications.

There you assess that industry's strengths, weaknesses, opportunities and threats, also exploring social, technological, economic and political questions. Those analyses give you feel for that market - its progress and potential. That way you're less likely to fall behind.

To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com

Neuromodulation technology and its uses - companies and 2018 market value 

What happens next? From 2015 those treatments hold great potential for investments, medical advances and sales. Our new report predicts the world market for those products will reach $8.1bn in 2018, with rapid expansion to 2025.

That work also explores activities and potentials of these companies and others:
• Medtronic
• Boston Scientific
• St. Jude Medical
• Cyberonics
• Stryker Corporation
• SetPoint Medical
• Functional Neuromodulation
• Neurotherapies Reset.

With our analysis you see how that market can develop and perform, benefiting your insight and authority. See there how you can help your research, analysis and planning.

Ways Neuromodulation Devices: World Industry and Market 2015-2025 helps you 

That new study benefits your work in seven main ways:
• Revenue to 2025 for the neuromodulation devices market - discover the overall sales potential of that industry
• Predictions to 2025 for its submarkets - investigate sales categories at world level, finding the most lucrative and promising product groups
• Forecasts to 2025 for national markets in the Americas, Europe and Asia - discover the best countries and regions for commercial expansion
• Activities of established, rising and emerging companies - hear about firms' products, capabilities, advances and outlooks
• Research and development - investigate progress, exploring technological, clinical and commercial opportunities
• Interviews with companies - discover what participants think, say and do, helping you stay ahead in knowledge
• Analysis of what stimulates and restrains that market - assess challenges and strengths of that industry, to help you compete and gain advantages.

There you find original business intelligence - knowledge found only in that investigation.

Trying our analysis now lets you discover trends, opportunities and predictions
Our new study shows you data, trends, opportunities and sales forecasts to 2025 for neuromodulation therapy. Avoid missing out. Instead please get that report here now.

To request an exec summary of this report please email Sara Peerun at sara.peerun@visiongainglobal.com or call Tel: +44-(0)20-7336-6100

Or click on https://www.visiongain.com/Report/1348/Neuromodulation-Devices-World-Industry-and-Market-2015-2025

Companies Listed on this report 

Accellent
Accuitive Medical Ventures (AMV)
Advanced Bionics
Avery Biomedical
Axonics Modulation Technologies
Bard Electrophysiology
Bayer AG
Boston Scientific
Boston Scientific Innovation Centre (Shanghai, China)
Boston Scientific Institute for Advancing Science (Shanghai, China)
CardioMems
Cerbomed GmbH
CerebralRx
Cirtec
Cochlear
Covidien
Cyberonics
Deep Brain Innovations
Department of Justice (US)
electroCore
European Commission
Foundation Medical Partners
Functional Neuromodulation
Genesys Capital
GlaxoSmithKline (GSK)
Halo Neuroscience
ImThera Medical
IoGyn
Johnson & Johnson
Magstim
Mainstay Medical
Med-El
Medtronic
Mindray
Ministry of Health, Labour and Welfare (Japan)
Nanostim
National Health Service (UK)
National Institute for Health and Care Excellence (NICE, UK)
NDI Medical
NEA
NeuroStar
Neurotherapies Reset
NeuroTherm
Nevro Corp.
NOVO A/S
Pfizer
Pharmaceuticals and Medical Devices Agency (PMDA)
Roche
Sapiens Steering Brain Stimulation (Purchased by Medtronic)
SceneRay
SetPoint Medical
St. Jude Medical
StarMedTec
Stryker Corporation
Synova
Tyler Laboratory of Neuroscience and Neurotechnology
Uroplasty
US Food and Drug Administration (FDA)
Wiringless Implantable Stretchable Electronics (WISE)

To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.